Treatment of Tinnitus With Noninvasive Neuromodulation and Listening Therapy

Launched by UNIVERSITY OF ARIZONA · Jun 14, 2021

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to help people with tinnitus, which is a condition that causes ringing or buzzing in the ears, and hyperacusis, where sounds seem louder than they actually are. The researchers want to see if a method called transcranial direct current stimulation (or tDCS) combined with listening therapy can improve these conditions. This study is not yet open for participants, but it aims to include adults aged 18 to 80 who have experienced chronic tinnitus or hyperacusis for more than eight months.

To be part of the trial, you should not have any implanted metal devices, such as cochlear implants, or a history of certain health issues like severe neurological disorders or epilepsy. If you qualify and decide to participate, you'll receive non-invasive treatment that combines gentle brain stimulation and listening exercises designed to help reduce the symptoms of tinnitus and hyperacusis. Overall, this trial is an exciting opportunity to explore new treatments for these challenging hearing disorders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • chronic tinnitus and or hyperacusis (\> 8 months)
• • adults (18-80 years old)
• Exclusion Criteria:
• • implanted metal or devices including cochlear implants,
• • bullet wounds, head/neck tattoo,
• • metal in the eyes,
• • other diagnosed neurological disorders (e.g., stroke, Parkinson's, dementia, brain tumors),
• • head trauma or brain surgery, psychiatric disorders,
• • personal or family history of epilepsy, other seizure disorders
• • Individuals with a history of Meniere's Disease, pulsatile tinnitus, otosclerosis, and
• • chronic headaches.
• • conductive hearing loss, or
• • fluctuating hearing thresholds
• • pure tone averages \>70dB HL